Business Context and Reporting Period
This Form 8-K Current Report from CareTrust REIT, Inc. (CTRE) covers events occurring on December 9, 2021, with the report filed on December 10, 2021. The filing primarily addresses significant changes in executive leadership and board composition.
Key Financial Metrics
This filing does not contain operational financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on executive compensation arrangements and personnel changes.
Material Changes
- CEO Transition: Greg Stapley resigned as Chief Executive Officer, effective January 1, 2022. He will serve as Executive Chairman during a six-month transition period before departing for a three-year volunteer assignment.
- New CEO Appointment: David Sedgwick, currently President and Chief Operating Officer, was appointed CEO, effective January 1, 2022. He will retain his role as President.
- Board Appointment: Diana M. Laing was appointed as Lead Independent Director.
- Compensation Adjustments:
- Greg Stapley's 2022 base salary is set at $809,325 (pro-rated). He will not participate in the short-term incentive plan for 2022.
- David Sedgwick's 2022 base salary is set at $700,000. His target annual cash award under the short-term incentive plan increases from $475,000 (2021) to $1,000,000 (2022).
- Target equity awards for 2022 are $272,500 for Mr. Stapley and $1,300,000 for Mr. Sedgwick, subject to Compensation Committee approval.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, outlook, or management commentary regarding business performance. The primary risk disclosed relates to the transition of leadership and the associated changes in executive compensation structures. The document notes that Mr. Sedgwick is Mr. Stapley's brother-in-law but confirms no other material family relationships or undisclosed related party transactions exist.
Investor Verification Checklist
- Verify the effective date of the CEO transition (January 1, 2022) and the duration of the transition period.
- Confirm the specific performance targets for Mr. Sedgwick's short-term and long-term incentive plans, which are determined by the Compensation Committee.
- Review the Company's Definitive Proxy Statement (Schedule 14A) filed on March 19, 2021, for Mr. Sedgwick's biographical information.
- Monitor future filings for the formal approval of the 2022 equity awards mentioned as subject to early 2022 approval.